May 8, 2024

Columbia University Obesity Treatment: Nanotechnology Reduces Fat at Targeted Locations

By Columbia University School of Engineering and Applied Science
December 8, 2022

Difficulties in targeting fat cells.
For numerous people, the capability to target fat cells and safely uncouple unhealthy fat development from healthy fat metabolic process would be a dream come real. A major difficulty in weight problems treatment is that fat tissue is not continuous in the body but is found piece by piece in “depots.” It has been tough to target in a depot-specific way, identified at the specific location.
There are 2 primary sort of fat. Visceral fat is internal tissue that surrounds the stomach, liver, and intestinal tracts. Subcutaneous fat is discovered under the skin throughout the body. Visceral fat produces potbellies, while subcutaneous fat can create chin jowls, arm fat, and so on. To date, there has been no way to specifically deal with visceral fat. In addition, current treatments for subcutaneous fat like liposuction are destructive and intrusive.
Illustration of depot-specific targeting of fat by cationic nanomaterials. Credit: Nicoletta Barolini/Columbia University
New studies use cationic nanonmaterials to target fat
2 brand-new studies from scientists at Columbia Engineering and Columbia University Irving Medical Center (CUIMC) may have the response to targeting fat cells depot-specifically and healthily. The papers show a new approach to treat weight problems by utilizing cationic nanomaterials that can target specific areas of fat and prevent the unhealthy storage of bigger fat cells. The products redesign fat rather than ruining it, as, for instance, liposuction does.
The first paper, which was released on December 1 in the journal Nature Nanotechnology, focuses on visceral adiposity, or stubborn belly fat. The second paper, released online on November 28 in the journal Biomaterials, focuses on fat below the skin in addition to chronic inflammation related to weight problems.
The group of researchers, led by Li Qiang, associate teacher of pathology and cell biology at CUIMC, and Kam Leong, Samuel Y. Sheng Professor of Biomedical Engineering and of systems biology at CUIMC, acknowledged that adipose tissue consists of big quantities of adversely charged extracellular matrix (ECM) to hold fat cells. The P-G3 quickly spread out throughout the group and the tissue was thrilled that their approach to particularly target visceral fat worked.
Unforeseen outcomes
And after that something appealing took place: P-G3 shut down the lipid storage program in fat cells and the mice dropped weight. This was totally unforeseen, offered the well-established function of P-G3 in reducing the effects of adversely charged pathogens, such as DNA/RNA cell particles, to minimize swelling.
” Our method is unique– It leaves from the surgical or pharmacological methods,” says Qiang, who specializes in obesity and adipocyte biology. “We utilized cationic charge to revitalize healthy fat cells, a technique nobody has ever utilized to treat obesity. I believe this unique technique will unlock to healthier and more secure reduction of fat.”
P-G3 helps brand-new fat cell development and likewise prevents the unhealthy lipid storage of enlarged fat cells
In these two studies, the scientists discovered that the cationic product, P-G3, could do an intriguing thing to fat cells– while it assisted new fat cell formation, it also uncoupled lipid storage from the housekeeping functions of fat cells. And because it hinders the unhealthy lipid storage of enlarged fat cells, the mice had more metabolically healthy, young, little fat cells like those discovered in athletes and newborns. The researchers found that this uncoupling function of P-G3 also is true in human fat biopsies, symbolizing the potential of translation in human beings.
” With P-G3, fat cells can still be fat cells, however they cant mature,” stated Leong, a pioneer in utilizing polycation to scavenge pathogens. “Our research studies highlight an unforeseen technique to deal with visceral adiposity and recommend a brand-new direction of exploring cationic nanomaterials for treating metabolic illness.”
New applications for drug delivery, gene treatment, and visual appeals
Now that they can selectively target visceral fat, Leong and Qiang visualize several applications. The Biomaterials research study demonstrates an easy method that could be used for aesthetic functions; like Botox, P-G3 can be locally injected into a particular, subcutaneous fat depot. The investigators, who have patents pending, are now engineering P-G3 into various derivatives to improve the depot, efficacy, and safety specificity.
What the scientists are particularly excited about is establishing P-G3 into a platform that can provide drugs and gene treatments particularly to an offered fat depot. This might repurpose numerous drugs from systemic security issues, such as Thiazolidinediones (TZDs), a powerful however unsafe drug that is a strong modulator of fat and used to treat type 2 diabetes– however it has actually been linked to heart failure and banned in a number of nations.
” Were really thrilled to discover that cationic charge is the trick to targeting adipose tissue,” Qiang said. “Now we can shrink fat in a depot-specific way– anywhere we want– and in a safe method without destroying fat cells. This is a significant advance in treating weight problems.”
Recommendations:
” Selective targeting of visceral adiposity by polycation nanomedicine” by Qianfen Wan, Baoding Huang, Tianyu Li, Yang Xiao, Ying He, Wen Du, Branden Z. Wang, Gregory F. Dakin, Michael Rosenbaum, Marcus D. Goncalves, Shuibing Chen, Kam W. Leong and Li Qiang, 1 December 2022, Nature Nanotechnology.DOI: 10.1038/ s41565-022-01249-3.
” Polycationic PAMAM ameliorates obesity-associated chronic swelling and focal adiposity” by Baoding Huang, Qianfen Wan, Tianyu Li, Lexiang Yu, Wen Du, Carmen Calhoun, Kam W. Leong and Li Qiang, 28 November 2022, Biomaterials.DOI: 10.1016/ j.biomaterials.2022.121850.

The development of fat cells, which are produced from a small fibroblast-like progenitor, not just activates the fat cells particular genes however likewise grows them by keeping more lipids (adipocytes and adipose tissue). For lots of people, the capability to target fat cells and safely uncouple unhealthy fat formation from healthy fat metabolic process would be a dream come real. Visceral fat produces potbellies, while subcutaneous fat can create chin jowls, arm fat, and so on. In these two research studies, the scientists found that the cationic product, P-G3, might do an appealing thing to fat cells– while it assisted brand-new fat cell formation, it likewise uncoupled lipid storage from the housekeeping functions of fat cells. And due to the fact that it hinders the unhealthy lipid storage of enlarged fat cells, the mice had more metabolically healthy, young, little fat cells like those found in athletes and babies.

Illustration of depot-specific targeting of fat by cationic nanomaterials. Credit: Nicoletta Barolini/Columbia University
Positively Charged Nanomaterials Treat Obesity Anywhere You Want
Columbia University scientists find that the cationic-charged P-G3 minimizes fat at targeted places by hindering the unhealthy lipid storage of enlarged fat cells
For a long period of time, researchers have been dealing with how to deal with weight problems, a major condition that can cause diabetes, high blood pressure, persistent inflammation, and heart diseases. Studies have actually also revealed a strong connection in between obesity and cancer. In fact, recent information show that smoking, drinking alcohol, and weight problems are the biggest factors to cancer worldwide.
The development of fat cells, which are produced from a tiny fibroblast-like progenitor, not only triggers the fat cells particular genes however also grows them by keeping more lipids (adipocytes and fat). Lipid storage is the defining function of a fat cell. However the storage of too much lipid can make fat cells unhealthy and result in obesity.